Rapid response to spesolimab in a patient with severe refractory pyoderma gangrenosum. Ma L, Chen X, Guo Q, Qiao Z, et al. Clin Exp Dermatol 2023;49:82-84.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ma L, Chen X, Guo Q, Qiao Z, et al. Rapid response to spesolimab in a patient with severe refractory pyoderma gangrenosum. Clin Exp Dermatol 2023;49:82-84.
PMID: 37706345